Global Sequencing Approach for Characterizing the Molecular Background of Hereditary Iron Disorders
Authors:
- Muriel Giansily-BlaizotMGMuriel Giansily-Blaizot
- Michael BismuthMBMichael Bismuth
- François BlancFBFrançois Blanc
- Olivier DereureODOlivier Dereure
- Dominique LarreyDLDominique Larrey
- Alain Le QuellecAQAlain Le Quellec
- Philippe PouderouxPPPhilippe Pouderoux
- Christian RoseCRChristian Rose
- Isabelle RaingeardIRIsabelle Raingeard
- Eric RenardEREric Renard
- Jean-François SchvedJSJean-François Schved
- 5 October 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 53 (12) , 2060-2069
Abstract
Background: New genetic forms of hereditary hemochromatosis (HH) or hereditary hyperferritinemia (HF) have been identified over the last few years, and abnormalities of various genes may interact in a single patient. This study aimed to develop a rapid automated method for sequencing the main genes involved. Methods: We used a standard 96-well microplate with a single PCR condition in an adaptation of the SCAIP (single-condition amplification with internal primer) method to sequence the HFE (hemochromatosis), HAMP (hepcidin antimicrobial peptide), HFE2/HJV [hemochromatosis type 2 (juvenile)], SLC40A1 (ferroportin), and TFR2 (transferrin receptor 2) genes, and the 5′ untranslated region of the FTL (ferritin, light polypeptide) gene. To further simplify the method, we adjusted PCR conditions to avoid the use of an internal primer and applied this single-condition amplification method to 38 selected, unrelated patients. We tailored the genetic investigation according to the clinical picture, with the patients falling into 2 groups. Group 1 consisted of patients with hyperferritinemia and high transferrin saturation (TS) (classic adult and juvenile HH forms, groups 1A and 1B, respectively), and group 2 consisted of patients with hyperferritinemia and low, typical, or slightly increased TS, with or without iron overload (groups 2A and 2B, respectively). Results: With this strategy we identified single-gene and multigene abnormalities, including 6 previously undescribed abnormalities in HFE (c.794dupA), HFE2 (c.–89–4dupT), and SLC40A1 (c.262A>G, c.533G>A, c.1468G>A, and c.–59_–45del). Conclusion: This method is a simple approach for investigating hereditary iron overload or HF and allows rapid evaluation of patients.Keywords
This publication has 32 references indexed in Scilit:
- Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%Journal of Medical Genetics, 2006
- Microelectronic DNA chip for hereditary hyperferritinemia cataract syndrome, a model for large-scale analysis of disorders of iron metabolismHuman Mutation, 2006
- The Q283P amino-acid change in HFE leads to structural and functional consequences similar to those described for the mutated 282Y HFE proteinHuman Genetics, 2005
- The ferroportin diseaseBlood Cells, Molecules, and Diseases, 2004
- Identification of New Mutations of the HFE, Hepcidin, and Transferrin Receptor 2 Genes by Denaturing HPLC Analysis of Individuals with Biochemical Indications of Iron OverloadClinical Chemistry, 2003
- Rapid detection of novelBRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragmentsHuman Mutation, 2002
- Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USAThe Lancet, 2002
- Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiencyEuropean Journal of Human Genetics, 2001
- A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosisNature Genetics, 1996
- Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataractNature Genetics, 1995